Brianna Lowey

Brianna Lowey

Auto-generated profile, based on publicly available information

Brianna Lowey

Department of Immunobiology, Yale School of Medicine, New Haven, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2019 in Nature
Verified
Journal Article
Closed access
PDF file
AWAaron T. Whiteley
Aaron T. Whiteley
JEJames B. Eaglesham
James B. Eaglesham
CMCarina C. de Oliveira Mann
Carina C. de Oliveira Mann
BMBenjamin R. Morehouse
Benjamin R. Morehouse
BLBrianna Lowey
Brianna Lowey
PKPhilip J. Kranzusch
Philip J. Kranzusch

2 September 2020 in Nature
Verified
Journal Article
Closed access
PDF file
BMBenjamin R. Morehouse
Benjamin R. Morehouse
AGApurva A. Govande
Apurva A. Govande
AMAdi Millman
Adi Millman
AKAlexander F. A. Keszei
Alexander F. A. Keszei
BLBrianna Lowey
Brianna Lowey
PKPhilip J. Kranzusch
Philip J. Kranzusch

13 January 2022 in Science
Verified
Journal Article
Closed access
AJAlex G. Johnson
Alex G. Johnson
TWTanita Wein
Tanita Wein
MMMegan L. Mayer
Megan L. Mayer
BDBrianna Duncan-Lowey
Brianna Duncan-Lowey
EYErez Yirmiya
Erez Yirmiya
PKPhilip J. Kranzusch
Philip J. Kranzusch
Ancient origin of cell death: Gasdermins are cell death proteins in mammals that form membrane pores in response to pathogen infection. Johnson et al . report that diverse bacteria encode structural and functional homologs of mammalian gasdermins. Like their mammalian counterparts, bacterial gasdermins are activated by caspase-like proteases, oligomerize into large membrane pores, and defend against pathogen—in this case, bacteriophage—infection. Proteolytic activation occurs through the release of a short inhibitory peptide, and many bacterial gasdermins are lipidated to facilitate membrane pore formation. Pyroptotic cell death, a central component of mammalian innate immunity, thus has a shared origin with an ancient antibacteriophage defense system. —SMH

1 February 2020 in Molecular Cell
Verified
Journal Article
Closed access
RLRebecca K. Lau
Rebecca K. Lau
QYQiaozhen Ye
Qiaozhen Ye
EBErica A. Birkholz
Erica A. Birkholz
KBKyle R. Berg
Kyle R. Berg
LPLucas Patel
Lucas Patel
KCKevin D. Corbett
Kevin D. Corbett

1 December 2021 in Molecular Cell
Verified
Journal Article
Closed access
BDBrianna Duncan-Lowey
Brianna Duncan-Lowey
NMNora K. McNamara-Bordewick
Nora K. McNamara-Bordewick
NTNitzan Tal
Nitzan Tal
RSRotem Sorek
Rotem Sorek
PKPhilip J. Kranzusch
Philip J. Kranzusch

2 February 2022 in Current Opinion in Immunology
Verified
Journal Article
Open access
BDBrianna Duncan-Lowey
Brianna Duncan-Lowey
PKPhilip J Kranzusch
Philip J Kranzusch
Cyclic oligonucleotide-based antiphage signaling system (CBASS) immunity is a widespread form of antiphage defense in bacteria and archaea. Each CBASS operon encodes a cGAS/DncV-like Nucleotidyltransferase (CD-NTase) enzyme that synthesizes a nucleotide second messenger in response to viral infection. An associated Cap effector protein then binds the nucleotide signal and executes cell death to destroy the host cell and block phage propagation. Here we build upon recent advances to establish rules controlling each step of CBASS activation and antiphage defense. Comparative analysis of CBASS, CRISPR, Pycsar, and cGAS-STING immunity provides insight into the evolution of phage defense and animal innate immunity and highlights new questions emerging in the role of nucleotide second messenger signaling in host-virus interactions.